Roche’s Virtual Event following ASH 2020 Webcast Replay
Roche has hosted a virtual event on Tuesday, 8 December 2020.
| Agenda: | |
|---|---|
| Welcome | Karl Mahler, Head of Investor Relations and Roche Group Planning |
| Hematology Franchise Overview | Thomas Fuchs, Vice President, Hematology Franchise Head, Global Product Strategy |
| Review of Key Clinical Data Presented at ASH | Ginna Laport, Vice President & Global Head of Hematology NHL/CLL Marion Ott, M.D., PhD - Global Franchise Head AML, Multiple Myeloma and Pediatric Development |
| Q&A |
Webinar Replay
Investors